Why the study?
What are the clinical implications and risk factors associated with drug-induced QT prolongation and torsades de pointes?
Population
Patients at risk for drug-induced torsades de pointes, including those with congenital long QT syndrome…
Design
Review
Authors
Loading...
Requires QT risk assessment before prescribing these agents; confirms known associations but leaves optimal mitigation open.
What are the clinical implications and risk factors associated with drug-induced QT prolongation and torsades de pointes?
Drug-induced QT prolongation is a significant clinical challenge that requires careful consideration of patient risk factors and drug interactions to prevent fatal arrhythmias.
Luigi X. Cubeddu (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: